EaglePicher Pharmaceutical Services
1985
FOUNDED
M&A
STATUS
51-60
EMPLOYEES
Buyout/LBO
LATEST DEAL TYPE
1
FINANCING ROUNDS
2
INVESTMENTS
Description
Manufacturer of anti-cancer active pharmaceutical ingredients and high-potency compounds. The company's services include early-to-stage product development, potent compound manufacturing, radiolabeling, analytical services, and regulatory support services. It serves government, research, radiochemical, and API production syntheses sectors.
Formerly Known As
Midwest Research Institute
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 13605 West 96th Terrace
- Lenexa, KS 66215
- United States
+1 (913) 000-0000
EaglePicher Pharmaceutical Services Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore EaglePicher Pharmaceutical Services‘s full profile, request access.
Request full access to PitchBookEaglePicher Pharmaceutical Services Investments (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 | 17-Nov-2008 | 00000 00000 00 | 000 | Diagnostic Equipment | |
| Evogen | 04-Apr-2002 | Early Stage VC | 00.00 | Diagnostic Equipment |
EaglePicher Pharmaceutical Services Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Scott Parker | Director, Business Development & Sales Manager |
1 Former Executive
You’re viewing 1 of 2 executives. Get the full list »